Endocervical adenocarcinoma in situ with ovarian metastasis: a case report

Background: Ovarian metastases, which may simulate primary ovarian neoplasms, can occur in advanced stage primary cervical adenocarcinoma (AC). However, such tumors are very rarely observed in cases of endocervical adenocarcinoma in situ (AIS) with early or even no obvious signs of tumor invasion. Case: We present a case of ovarian metastasis occurring in a 37-year-old triparous premenopausal woman with a diagnosed case of endocervical AIS. The patient presented with a rapidly growing and painful abdominal mass 22 months after a cold knife cone biopsy and 19 months after a simple extrafascial hysterectomy. She was subsequently treated with a combination of surgery and chemotherapy and is currently free of disease seven years after the initial diagnosis of endocervical AIS lacking unequivocally recognizable stromal invasion. Conclusion: Endocervical AIS with early or even no obvious detectable invasion may spread to the ovaries, but this situation is exceptionally rare. We propose that, in such cases, ovary sparing surgery is justifiable for initial treatment. Medical care strategies for patients affected by rare diseases largely depend on experience gained from reported cases in published literature, this is what compelled us to report this particular case.

Ovarian metastasis; Adenocarcinoma in situ; Uterine cervix.

[1] Bray F.: ”Incidence Trends of Adenocarcinoma of the Cervix in 13 European Countries”. Cancer Epidemiol. Biomarkers Prev., 2005, 14, 2191-2199.

[2] Chan P.G., Sung H.-Y., Sawaya G.F.: ”Changes in Cervical Cancer Incidence After Three Decades of Screening US Women Less Than 30 Years Old”. Obstet. Gynecol., 2003, 102, 765-773.

[3] Quinn M.A., Benedet J.L., Odicino F., Maisonneuve P., Beller U., Creasman W.T., et al.: ”Carcinoma of the Cervix Uteri”. Int. J. Gynecol. Obstet., 2006, 95, S43-S103.

Bullphelps S., Garner E., Walsh C., Gehrig P., Miller D., Schorge J.: ”Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix”. Gynecol. Oncol., 2007, 107, 316-319. Reynolds E.A., Tierney K., Keeney G.L., Felix J.C., Weaver A.L., Roman L.D., et al.: ”Analysis of Outcomes of Microinvasive Adenocarcinoma of the Uterine Cervix by Treatment Type”. Obstetr. Gynecol., 2010, 116, 1150-1157.

[6] Smrkolj Š., Pogačnik R.K., Slabe N., Rakar S.: ”Clinical outcome of patients with FIGO stage IA2 squamous cell carcinoma of the uterine cervix”. Gynecol.c Oncol., 2012, 124, 68-71.

[7] Touhami O., Plante M.: ”Erratum to “Should ovaries be removed or not in (early-stage) adenocarcinoma of the uterine cervix: A review” [Gynecol. Oncol. 136 (2015) 384–388]”. Gynecol. Oncol.,2015, 137, 600.

[8] Meglic L., Pogacnik R.K., Rakar S., Smrkolj S.J.E.J.o.G.O.: ”Clinical outcome of patients with microinvasive adenocarcinoma of the uterine cervix”. 2013, 34, 296-299.

[9] Shimada M., Kigawa J., Nishimura R., Yamaguchi S., Kuzuya K., Nakanishi T., et al.: ”Ovarian metastasis in carcinoma of the uterine cervix”. Gynecol. Oncol., 2006, 101, 234-237.

[10] Nakanishi T., Wakai K., Ishikawa H., Nawa A., Suzuki Y., Nakamura S., et al.: ”A Comparison of Ovarian Metastasis between Squamous Cell Carcinoma and Adenocarcinoma of the Uterine Cervix”. Gynecol. Oncol., 2001, 82, 504-509.

[11] Chang M.C., Nevadunsky N.S., Viswanathan A.N., Crum C.P., Feltmate C.M.: ”Endocervical Adenocarcinoma In Situ With Ovarian Metastases: A Unique Variant With Potential for Long-term Survival”. Int. J. Gynecol. Pathol., 2010, 29, 88-92.

[12] Ronnett B.M., Yemelyanova A.V., Vang R., Gilks C.B., Miller D., Gravitt P.E., et al.: ”Endocervical Adenocarcinomas With Ovarian Metastases”. Am. J. Sur. Pathol., 2008, 32, 1835-1853.

[13] Tabata M., Ichinoe K., Sakuragi N., Shiina Y., Yamaguchi T., Mabuchi Y.: ”Incidence of ovarian metastasis in patients with cancer of the uterine cervix”. Gynecol. Oncol., 1987, 28, 255-261.